IBC Home | Registration Procedures | Registration Descriptions | Submission Info | Links | Committee Members | Contact Info
The Institutional Biosafety Committee reviews registrations for Recombinant DNA, Pathogens, Infectious Agents, Biological Toxins, and Human Gene Therapy/Pathogen Clinical Trials as mandated by the National Institutes of Health and/or Johns Hopkins Institutions Policies. The full IBC meets monthly for discussion and voting. A subgroup of the IBC meets one week prior to the full meeting to triage protocols for missing information necessary for full IBC review.
Registrations that require IBC review are assembled into packets at the end of each month and delivered to the IBC members the following week. The IBC triage meeting is normally scheduled for the second Tuesday of every month. The full IBC meeting is normally scheduled for the third Monday of every month.
The Biosafety Office of the Johns Hopkins Institutions registers the use or possession of Recombinant DNA, Pathogens, Toxins, and Human Tissues on the Homewood, East Baltimore, Bayview and Montgomery County campuses.
Investigators are responsible for registering research materials and describing the protocols in which they will be used. This rule applies to all independent investigators. Collaborators may not "piggy-back" on each others' registrations. Postdoctoral fellows, graduate students and research associates are covered by the registrations of their Principal Investigator.
The Principal Investigator is ultimately responsible for the registration, training, and safe handling of research materials handled by their personnel.
